Fig. 1. Co-Mutation Patterns & adverse cytogenetic findings observed in the TP53 Cohort.

This figure illustrates the patterns of co-mutations identified in the TP53 cohort, categorized by treatment arm. Additionally, the data was further stratified based on two groups: the patients who achieved CR/CRi (A) and the primary refractory group (B).